Wednesday, May 15 2013 11:45 AM EDT2013-05-15 15:45:20 GMT
While cold and flu season is widely discussed, pneumonia season is quickly gaining the spotlight. One in 20 dies from the lung disease each year, and it's what's going around this week. What is pneumonia? PneumoniaMore >>
While cold and flu season is widely discussed, pneumonia season is quickly gaining the spotlight. One in 20 dies from the lung disease each year, and it's what's going around this week.More >>
Wednesday, May 8 2013 9:06 AM EDT2013-05-08 13:06:30 GMT
We all have our aches in our bellies and backs from time to time, but these pains can also be signs of gallstones. Dr. Hatem Mourad from Coastal Urgent Care and Family Medicine warns that gallstones areMore >>
Dr. Hatem Mourad from Coastal Urgent Care and Family Medicine warns that gallstones are what's going around.More >>
Medical Central is the source for local doctors to advertise their businesses, as well as provide clients and viewers with valuable information on their fields of study.More >>
Jessica Foster is originally from Atlanta, Georgia and has worked at WMBB since 2004. She is excited to bring the news to you each weekday on News13 This Morning. Jessica produces 3 medical segments weekly- What's Going Around, Modern Medicine and Mayo Clinic reports.More >>
Medical Central is the source for local doctors to advertise their businesses, as well as provide clients and viewers with valuable information on their fields of study.More >>
Jessica Foster is originally from Atlanta, Georgia and has worked at WMBB since 2004. She is excited to bring the news to you each weekday on News13 This Morning. Jessica produces 3 medical segments weekly- What's Going Around, Modern Medicine and Mayo Clinic reports.More >>
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE Welichem Biotech Inc.
BURNABY, BC, March 1, 2013 /CNW/ - Welichem Biotech Inc. (the "Company")
(TSX-V: WBI), announced today that Mrs. Lijuan Pang has resigned as a
director of the Company effective March 1, 2013.
The Company has valued the contribution of Mrs. Pang as a director of
the Company over the past one and half years and wishes her success in
her future endeavours.
About Welichem Biotech Inc.
Welichem Biotech Inc. is a publicly-traded biotechnology company
developing therapeutic drugs in the fields of autoimmune diseases and
cancer. For a more complete business and financial profile of the
Company, interested parties are encouraged to visit the Company's
website, www.welichem.com.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of the content of this news
release. This press release contains forward-looking statements that
include our belief as to the potential of our products. Certain risks
and uncertainties such as our ability to successfully commercialize the
products could cause the Company's actual results to differ materially
from those in the forward-looking statements.
All content © Copyright 2000 - 2013 WorldNow and WMBB. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.
